Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts - Wikidata - awgldk - TriplyDB

Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts

Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts

http://www.wikidata.org/entity/Q36692575

about

Considerations for observational research using large data sets in radiation oncology Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival A review of routinely collected data studies in urology: Methodological considerations, reporting quality, and future directions Improving treatment and survival: a population-based study of current outcomes after a hepatic resection in patients with metastatic colorectal cancer.Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management.Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data.A Validation Study of Administrative Claims Data to Measure Ovarian Cancer Recurrence and Secondary Debulking Surgery.Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone.Limited validity of diagnosis codes in Medicare claims for identifying cancer metastases and inferring stage.An algorithm to identify the development of lymphedema after breast cancer treatment.Development of a claims-based algorithm to identify colorectal cancer recurrence.Challenges and opportunities in measuring cancer recurrence in the United States Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer Comparing cancer care, outcomes, and costs across health systems: charting the course.Using natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence.Clinical, pathological, and demographic factors associated with development of recurrences after surgical resection in elderly patients with neuroendocrine tumors.Factors Associated with Early Mortality Among Patients with De Novo Metastatic Breast Cancer: A Population-Based Study.Utilization Patterns and Trends in Epidermal Growth Factor Receptor (EGFR) Mutation Testing Among Patients With Newly Diagnosed Metastatic Lung Cancer.Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study.Racial variation in the clinical and economic burden of skeletal-related events among elderly men with stage IV metastatic prostate cancer.A validated algorithm to ascertain colorectal cancer recurrence using registry resources in Denmark.Lost in translation, or overestimating administrative data for outcome control in colorectal surgery.Cancer recurrence: an important but missing variable in national cancer registries.The influence of marital status on survival in patients with oral tongue squamous cell carcinoma.Survival after recurrence of stage I-III breast, colorectal, or lung cancer.Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women.Accuracy of lung cancer ICD-9-CM codes in Umbria, Napoli 3 Sud and Friuli Venezia Giulia administrative healthcare databases: a diagnostic accuracy study.Interactions between Alcohol Consumption and Adjuvant Hormone Therapy in Relation to Breast Cancer-Free Survival.Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm Non-participation in breast cancer screening among previous cancer patients

P2860

Q24289442-428EABDE-4C01-41B6-AFE0-0304AB5FA7B4 Q27022747-37228AF8-D26A-455C-B872-47D4825B38C1 Q29994492-D943E1CB-5FDE-48A6-90A6-6074E91FADD7 Q30278725-A3BCAE06-5C96-4D09-A47C-BB24B0E98F9A Q30725083-DEF69A83-CD24-44E5-A31F-9CC14B618899 Q30983918-7B089CF1-1F80-4308-BD57-3431D11B216A Q31025995-997892A8-9833-4B64-9F06-97D510088C61 Q31144976-36DC751A-BAB7-45B2-A743-B867E7ED4E68 Q33574428-0934B035-0577-4EE2-83A5-5BEDE2B448ED Q34055498-A932A111-78AE-47F2-A22D-F8DDBA545BA8 Q35185438-FC59FAC9-4816-4DE3-A2C1-CBE6DA4F87EB Q35205035-B66534B2-6A58-4ED3-809A-7414792E5448 Q36087206-CB9C13C2-B3E0-4110-ACE3-9B158442168B Q36263586-E9678090-733E-4A83-90BD-7330B9C16E70 Q37383675-34143AC8-E766-432C-972A-658FF738E02E Q37612592-F1CC41FF-0905-4341-8C79-94AE1A627EFE Q38690778-0A457E03-FC2A-44CE-9741-6D5F3783F6FE Q38938648-C3C38FCF-7591-4E35-B4AB-80479C592D05 Q39063642-8C676145-5152-4930-AEE3-1545E1F6AE7E Q39198613-CE9E1E64-926C-4EB9-AE19-48DE93E90D38 Q41147765-C9151D98-A275-4869-A894-54626C1AEE3A Q45060943-21803E9F-B1CD-4396-8C2B-60E154E35E1F Q45411015-F7ADB759-47C5-40B1-AC9A-FE45E64BF737 Q46632410-4BD4FBC2-13CE-4C16-934C-8B63AA8751BE Q47162840-1F994607-6BA5-4AB6-99EE-85FAFDC57475 Q50528546-F06F8BE2-3852-4ACF-AE86-9505924C8E53 Q50899870-1C411F21-BD96-4454-B720-E44E3E4AF28A Q55110933-8C4F9DD9-B987-40BF-A37A-3D9F143E2A8E Q55357811-40B788B7-9487-45EA-83BB-C6A697F44D8C Q57114388-F5548052-773E-4933-977F-17934572CB4F Q58788826-ECBC31CB-6362-406C-85F3-EA8AE7A606AF

P2860

Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts

http://www.wikidata.org/entity/Q36692575

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Validating billing/encounter c ...... g 2 large contemporary cohorts

@ast

Validating billing/encounter c ...... g 2 large contemporary cohorts

@en

type

label

Validating billing/encounter c ...... g 2 large contemporary cohorts

@ast

Validating billing/encounter c ...... g 2 large contemporary cohorts

@en

prefLabel

Validating billing/encounter c ...... g 2 large contemporary cohorts

@ast

Validating billing/encounter c ...... g 2 large contemporary cohorts

@en

P1433

Q36692575-79572DA1-98AA-4266-9AC4-8B8AF646679D

P1476

Q36692575-C45C5FDD-994D-4545-87A0-794EDA3897AF

P2093

Q36692575-2D24479A-EB13-4B84-833E-3B651959758C

Q36692575-5D3C7744-9671-4F7C-BAD6-AD8F59A230AC

Q36692575-6441C5DB-363C-4BE6-9323-3D39C0845283

Q36692575-6A3A64DC-EA37-4258-93CC-C74F71CB128D

Q36692575-816E6BA7-9B73-4D04-ACD2-49BFCD1C4C1D

Q36692575-BF80AEE0-DAD0-46F2-8700-68F4D1997879

Q36692575-C056645C-8E07-4854-BB79-1DFD3B5AEE70

Q36692575-D87869C8-E229-44C7-B0B7-78A40503F1C0

Q36692575-DD397A95-C4CF-409D-9234-D3317A54886D

Q36692575-EBDD82CF-8322-4D29-A156-7E0C0435223E

P2860

Q36692575-0BDF7DB9-0CF3-4DA4-9266-315FA46D995A

Q36692575-0BF54C13-F9AC-4BFE-9CFB-686F47C39D3C

Q36692575-61999AC0-9A4F-43F5-A411-67FA22345E00

Q36692575-62CD86B8-E875-41F8-9FBB-DE6DCDA1CE6F

Q36692575-74A58E78-0BC4-46AD-96A4-D71B71E070C1

Q36692575-77FDE600-E63F-4866-94C0-E4B34256C509

Q36692575-8F491C5A-DCEF-4C40-ABCA-9089E23500D2

Q36692575-91B3ECB9-85D1-42A4-9CFF-63DDD4C4219C

Q36692575-A50F718A-AA4C-4C1E-B988-0FF11376DA9C

Q36692575-AB44B616-07F5-4597-9B05-76D44B3F5EB1

P304

Q36692575-1FB407A2-C724-45B9-BA9E-2A7F2D09CC7F

P31

Q36692575-D239BCED-42E2-426C-A00D-7234D16E5F19

P356

Q36692575-F675F5F8-36B9-4574-A7C9-4AB6FA861188

P433

Q36692575-0BC91C37-CA36-4B3C-85B0-0E2E01643C1E

P478

Q36692575-45ADABD6-C781-4AB0-95A4-26A435C4367E

P577

Q36692575-D5189E22-611D-484B-A570-716C18DC0BE4

P698

Q36692575-D69B2983-E728-46FB-8B31-A7C792C27865

P932

Q36692575-FDF84EA0-2477-4C78-8D54-020B6D950D1E

P356

MLR.0B013E318277EB6F

P1433

P1476

Validating billing/encounter c ...... g 2 large contemporary cohorts

@en

P2093

Angel M Cronin

http://www.w3.org/2001/XMLSchema#string

Deb Schrag

http://www.w3.org/2001/XMLSchema#string

Debra P Ritzwoller

http://www.w3.org/2001/XMLSchema#string

Gladys V Ting

http://www.w3.org/2001/XMLSchema#string

Jane C Weeks

http://www.w3.org/2001/XMLSchema#string

Joan L Warren

http://www.w3.org/2001/XMLSchema#string

Mark C Hornbrook

http://www.w3.org/2001/XMLSchema#string

Michael J Hassett

http://www.w3.org/2001/XMLSchema#string

Nathan Taback

http://www.w3.org/2001/XMLSchema#string

Nikki Carroll

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Identifying cancer relapse using SEER-Medicare data.

Deaths: preliminary data for 2009.

Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data.

The effect of hospital and surgeon volume on racial differences in recurrence-free survival after radical prostatectomy.

Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344)

Validation of electronic data on chemotherapy and hormone therapy use in HMOs.

Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer

Using Medicare claims to identify second primary cancers and recurrences in order to supplement a cancer registry.

Improved outcomes associated with higher surgery rates for older patients with early stage nonsmall cell lung cancer.

P304

e65-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MLR.0B013E318277EB6F

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23222531

http://www.w3.org/2001/XMLSchema#string

P932

3600389

http://www.w3.org/2001/XMLSchema#string